Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-25 @ 8:26 PM
Study NCT ID:
NCT00743769
Status:
WITHDRAWN
Last Update Posted:
2017-04-17
First Post:
2008-08-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
Sponsor:
RegeneRx Biopharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2017-01-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-08-27
First Submit QC Date:
None
Study First Post Date:
2008-08-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-13
Last Update Post Date:
2017-04-17
Last Update Post Date Type:
ACTUAL